학술논문
Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
Document Type
Article
Source
In: Clinical and Translational Gastroenterology . (Clinical and Translational Gastroenterology, 6 October 2021, 12(10):E00401)
Subject
Language
English
ISSN
2155384X